Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco E L Feitosa

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Journal of Obstetrics and Gynaecology Research|July 28, 2018
Interstitial and angular pregnancies: Case reports and differential diagnosisDenise E F Cordeiro, Júlio A G Alves, Francisco E L Feitosa
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2013
Titrated oral misoprostol solution versus vaginal misoprostol for labor inductionAlex S R Souza, Francisco E L Feitosa, Aurélio A R Costa, et al.
Reproductive Health|April 11, 2020
Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trialDaniele S M B Gattás, Melania M R de Amorim, Francisco E L Feitosa, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Journal of Obstetrics and Gynaecology Research|July 28, 2018
Interstitial and angular pregnancies: Case reports and differential diagnosisDenise E F Cordeiro, Júlio A G Alves, Francisco E L Feitosa
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2013
Titrated oral misoprostol solution versus vaginal misoprostol for labor inductionAlex S R Souza, Francisco E L Feitosa, Aurélio A R Costa, et al.
Reproductive Health|April 11, 2020
Misoprostol administered sublingually at a dose of 12.5 μg versus vaginally at a dose of 25 μg for the induction of full-term labor: a randomized controlled trialDaniele S M B Gattás, Melania M R de Amorim, Francisco E L Feitosa, et al.
Pageof 1